Search Results

There are 2673 results for: content related to: Cardiovascular Events in Subgroups of Patients During Primary Treatment of Hypertension With Candesartan or Losartan

  1. ACUTE EFFECTS OF CANDESARTAN ON RAT RENAL HAEMODYNAMICS AND PROXIMAL TUBULAR REABSORPTION

    Clinical and Experimental Pharmacology and Physiology

    Volume 32, Issue 9, September 2005, Pages: 714–720, Siriphun Hiranyachattada, Siriwan Saetew and Peter J Harris

    Version of Record online : 20 SEP 2005, DOI: 10.1111/j.1440-1681.2005.04253.x

  2. Mechanical activation of angiotensin II type 1 receptors causes actin remodelling and myogenic responsiveness in skeletal muscle arterioles

    The Journal of Physiology

    Volume 594, Issue 23, 1 December 2016, Pages: 7027–7047, Kwangseok Hong, Guiling Zhao, Zhongkui Hong, Zhe Sun, Yan Yang, Philip S. Clifford, Michael J. Davis, Gerald A. Meininger and Michael A. Hill

    Version of Record online : 13 OCT 2016, DOI: 10.1113/JP272834

  3. Effect of angiotensin II type 1 receptor antagonist on tumor growth and angiogenesis in a xenograft model of human bladder cancer

    Human Cell

    Volume 20, Issue 1, February 2007, Pages: 1–9, Michio KOSUGI, Akira MIYAJIMA, Eiji KIKUCHI, Takeo KOSAKA, Yutaka HORIGUCHI and Masaru MURAI

    Version of Record online : 14 MAY 2007, DOI: 10.1111/j.1749-0774.2007.00025.x

  4. You have free access to this content
    Pharmacokinetics and haemodynamics of candesartan cilexetil in hypertensive patients on regular haemodialysis

    British Journal of Clinical Pharmacology

    Volume 47, Issue 6, June 1999, Pages: 645–651, Marc Pfister, Franziska Schaedeli, Felix J. Frey and Dominik E. Uehlinger

    Version of Record online : 24 DEC 2001, DOI: 10.1046/j.1365-2125.1999.00939.x

  5. You have free access to this content
    Angiotensin II antagonism and plasma radioreceptor-kinetics of candesartan in man

    British Journal of Clinical Pharmacology

    Volume 45, Issue 6, June 1998, Pages: 567–573, Claudius Malerczyk, Bettina Fuchs, Gustav G. Belz, Susanna Roll, Raunhild Butzer, Kerstin Breithaupt-Grögler, Volker Herrmann, Steffen G. Magin, Anette Högemann, Barbara Voith and Ernst Mutschler

    Version of Record online : 4 JAN 2002, DOI: 10.1046/j.1365-2125.1998.00722.x

  6. Angiotensin receptor blockers for heart failure

    Intervention Review

    The Cochrane Library

    Balraj S Heran, Vijaya M Musini, Ken Bassett, Rod S Taylor and James M Wright

    Published Online : 18 APR 2012, DOI: 10.1002/14651858.CD003040.pub2

  7. You have free access to this content
    Antihypertensive Efficacy of Candesartan in Comparison to Losartan: The CLAIM Study

    The Journal of Clinical Hypertension

    Volume 3, Issue 1, January/February 2001, Pages: 16–21, George Bakris, 1 Alan Gradman, 2 Max Reif, 3 Marian Wofford, 4 Mark Munger, 5 Susan Harris, 6 Jennifer Vendetti, 6 Eric L. Michelson and 6 Rebecca Wang 6

    Version of Record online : 31 MAY 2007, DOI: 10.1111/j.1524-6175.2001.00826.x

  8. You have free access to this content
    Involvement of angiotensin II type 1 receptor on pathological remodeling and dysfunction in obstructed bladder

    International Journal of Urology

    Volume 19, Issue 5, May 2012, Pages: 457–464, Ken Aikawa, Takio Sakai, Kei Ishibashi, Homare Shiomi, Koji Sagawa, Shin Kumagai, Masao Kataoka, Hidenori Akaihata and Osamu Yamaguchi

    Version of Record online : 9 FEB 2012, DOI: 10.1111/j.1442-2042.2012.02965.x

  9. You have free access to this content
    AT2 receptor-mediated vasodilatation is unmasked by AT1 receptor blockade in conscious SHR

    British Journal of Pharmacology

    Volume 142, Issue 5, July 2004, Pages: 821–830, Xiao C Li and Robert E Widdop

    Version of Record online : 29 JAN 2009, DOI: 10.1038/sj.bjp.0705838

  10. Blood pressure lowering efficacy of angiotensin receptor blockers for primary hypertension

    Intervention Review

    The Cochrane Library

    Balraj S Heran, Michelle MY Wong, Inderjit K Heran and James M Wright

    Published Online : 8 OCT 2008, DOI: 10.1002/14651858.CD003822.pub2

  11. You have free access to this content
    Comparative clinical- and cost-effectiveness of candesartan and losartan in the management of hypertension and heart failure: a systematic review, meta- and cost-utility analysis

    International Journal of Clinical Practice

    Volume 65, Issue 3, March 2011, Pages: 253–263, A. M. Grosso, P. N. Bodalia, R. J. MacAllister, A. D. Hingorani, J. C. Moon and M. A. Scott

    Version of Record online : 1 FEB 2011, DOI: 10.1111/j.1742-1241.2011.02633.x

  12. You have free access to this content
    Subclinical alteration of taste sensitivity induced by candesartan in healthy subjects

    British Journal of Clinical Pharmacology

    Volume 57, Issue 6, June 2004, Pages: 807–812, Shuichi Tsuruoka, Michi Wakaumi, Kenta Nishiki, Nobutaka Araki, Kenichi Harada, Koichi Sugimoto and Akio Fujimura

    Version of Record online : 21 APR 2004, DOI: 10.1111/j.1365-2125.2003.02063.x

  13. You have free access to this content
    ACE Inhibitor Intolerance and Lessons Learned From the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Trials

    Congestive Heart Failure

    Volume 10, Issue 3, May/June 2004, Pages: 160–164, Domenic A. Sica

    Version of Record online : 23 FEB 2007, DOI: 10.1111/j.1527-5299.2004.02806.x

  14. You have free access to this content
    Treatment of Human Mesenchymal Stem Cells with Angiotensin Receptor Blocker Improved Efficiency of Cardiomyogenic Transdifferentiation and Improved Cardiac Function via Angiogenesis

    STEM CELLS

    Volume 29, Issue 9, September 2011, Pages: 1405–1414, Yohei Numasawa, Takehiro Kimura, Shunichiro Miyoshi, Nobuhiro Nishiyama, Naoko Hida, Hiroko Tsuji, Hikaru Tsuruta, Kaoru Segawa, Satoshi Ogawa and Akihiro Umezawa

    Version of Record online : 19 AUG 2011, DOI: 10.1002/stem.691

  15. A placebo-controlled comparison of the efficacy and tolerability of candesartan cilexetil, 8 mg, and losartan, 50 mg, as monotherapy in patients with essential hypertension, using 36-h ambulatory blood pressure monitoring

    International Journal of Clinical Practice

    Volume 60, Issue 4, April 2006, Pages: 391–398, J-P Baguet, 1 S. Nisse-Durgeat, 2 S. Mouret, 1 R. Asmar and 3 J-M Mallion 1

    Version of Record online : 20 MAR 2006, DOI: 10.1111/j.1368-5031.2006.00903.x

  16. You have free access to this content
    Role of NF-κβ and Oxidative Pathways in Atherosclerosis: Cross-Talk Between Dyslipidemia and Candesartan

    Cardiovascular Therapeutics

    Volume 31, Issue 6, December 2013, Pages: 381–387, Najah R. Hadi, Nasser Ghaly Yousif, Mohammed S. Abdulzahra, Bassim I. Mohammad, Fadhil G. al-amran, Murooge L. Majeed and Maitham G. Yousif

    Version of Record online : 27 NOV 2013, DOI: 10.1111/1755-5922.12033

  17. Altered pharmacokinetics and excessive hypotensive effect of candesartan in a patient with the CYP2C9*1/*3 genotype

    Clinical Pharmacology & Therapeutics

    Volume 74, Issue 5, November 2003, Pages: 505–508, Shinya Uchida, Hiroshi Watanabe, Shinichiro Nishio, Hisakuni Hashimoto, Keisuke Yamazaki, Hideharu Hayashi and Kyoichi Ohashi

    Version of Record online : 27 NOV 2003, DOI: 10.1016/j.clpt.2003.08.001

  18. You have free access to this content
    Efficacy and safety of oral candesartan cilexetil in patients with congestive heart failure

    European Journal of Heart Failure

    Volume 5, Issue 5, October 2003, Pages: 669–677, Akira Matsumori and on behalf of the assessment of response to candesartan in heart failure in Japan (ARCH-J) study investigators

    Version of Record online : 4 NOV 2003, DOI: 10.1016/S1388-9842(03)00162-4

  19. You have free access to this content
    Candesartan pretreatment is cerebroprotective in a rat model of endothelin-1-induced middle cerebral artery occlusion

    Experimental Physiology

    Volume 94, Issue 8, August 2009, Pages: 937–946, Adam P. Mecca, Timothy E. O'Connor, Michael J. Katovich and Colin Sumners

    Version of Record online : 17 JUN 2009, DOI: 10.1113/expphysiol.2009.047936

  20. Chronic AT1-receptor blockade does not alter cerebral oxygen supply/demand ratio during cardiopulmonary bypass in hypertensive patients

    Acta Anaesthesiologica Scandinavica

    Volume 52, Issue 1, January 2008, Pages: 73–80, E. KOTTENBERG-ASSENMACHER, P. MASSOUDY, H. JAKOB, T. PHILIPP and J. PETERS

    Version of Record online : 1 NOV 2007, DOI: 10.1111/j.1399-6576.2007.01479.x